Icosavax, Inc.
ICVX · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $315,418 | $411,060 | $100,649 | $358,112 |
| - Cash | $58,846 | $279,082 | $13,114 | $23,079 |
| + Debt | $8,795 | $0 | $4,947 | $0 |
| Enterprise Value | $265,367 | $131,978 | $92,482 | $335,033 |
| Revenue | $582 | $7,802 | $1,616 | $0 |
| % Growth | -92.5% | 382.8% | – | – |
| Gross Profit | -$1,261 | $7,720 | -$16,051 | -$4,157 |
| % Margin | -216.7% | 98.9% | -993.3% | – |
| EBITDA | -$94,198 | -$64,902 | -$18,522 | -$5,398 |
| % Margin | -16,185.2% | -831.9% | -1,146.2% | – |
| Net Income | -$88,458 | -$67,999 | -$19,185 | -$5,196 |
| % Margin | -15,199% | -871.6% | -1,187.2% | – |
| EPS Diluted | -2.23 | -3.78 | -6.67 | -0.51 |
| % Growth | 41% | 43.3% | -1,207.8% | – |
| Operating Cash Flow | -$61,675 | -$38,540 | -$14,208 | -$4,569 |
| Capital Expenditures | -$11,113 | -$1,006 | -$11 | $0 |
| Free Cash Flow | -$72,788 | -$39,546 | -$14,219 | -$4,569 |